Update on the HTA Coordination Group subgroup meetings held on April 25 and 26
Update on the HTA Coordination Group subgroup meetings held on April 25 and 26.
Their collective efforts will surely shape the HTA landscape in the long run.
Recent Posts
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Patients
Accelerating Review for Transformative Multiple Myeloma Therapy
The U.S. Food and Drug Administration (
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
The CHMP meeting highlights from December 2025 reveal major advancements in drug approvals. What were the key outcomes of the EMA's Committee for Medicinal Products for Human Use session held December 8-11? The committee recommended seven new medicines for approval. These target critical areas li...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggressive Prostate Cancer
AKEEGA BRCA2 Approval Ushers in Precision Era for mCSPC
The AKEEGA BRCA2 approval by the U.S. Food and Drug Administration (FDA) on December 12, 2025, represents a breakthrough for patients with BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC). Johnson & Johnson...